About Diamond Drugs
Diamond Drugs is a company based in Kolkata (India) founded in 1954. It operates as a B2B. The company has 84 employees as of March 31, 2022. Diamond Drugs offers products and services including Apilysin, Lycimond, Livolysin, Lycimond Aloe Vera, and Sovit. Diamond Drugs operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Kolkata, India
- Employees 84 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Diamond Drugs Private Limited
- Date of Incorporation 15 Dec, 2004
- Jurisdiction Kolkata, West Bengal, India
-
Annual Revenue
$2.66 M (USD)23.73as on Mar 31, 2022
-
Net Profit
$444.6 K (USD)99.37as on Mar 31, 2022
-
EBITDA
$591.45 K (USD)84.24as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
84
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Diamond Drugs
Diamond Drugs offers a comprehensive portfolio of products and services, including Apilysin, Lycimond, Livolysin, Lycimond Aloe Vera, and Sovit.
Appetizer syrup widely prescribed for digestive support
Cream for treating second-degree superficial burns
Pharmaceutical product for general medicinal use
Skin gel for soothing and healing purposes
Veterinary formulation for animal health care
Funding Insights of Diamond Drugs
Detailed funding history for Diamond Drugs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Diamond Drugs
Investment portfolio details for Diamond Drugs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Diamond Drugs
Detailed financials for Diamond Drugs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diamond Drugs Comparisons
Peer comparison for Diamond Drugs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Diamond Drugs
Diamond Drugs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| Locked | Locked | Locked |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Detailed competitors of Diamond Drugs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diamond Drugs
Complete news archive for Diamond Drugs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diamond Drugs
Diamond Drugs was founded in 1954.
Diamond Drugs is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.
As of Mar 31, 2022, the latest employee count at Diamond Drugs is 84.
Annual revenue of Diamond Drugs is $2.66M as on Mar 31, 2022.
Diamond Drugs, a Kolkata-based company, has been involved in pharmaceutical contract manufacturing and marketing for over six decades. It produces and supplies formulations, including OTC products, while adhering to ISO and cGMP standards. The company serves clients in Indias Eastern Zone, focuses on quality production, and explores new markets like Andaman and Nicobar Islands. It also engages in third-party manufacturing and product innovation.
Diamond Drugs's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Diamond Drugs offers Apilysin, Lycimond, Livolysin, Lycimond Aloe Vera, and Sovit.